Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Audentes Therapeutics, Inc. (BOLD)
|
Add to portfolio |
|
|
Price: |
$59.97
| | Metrics |
OS: |
45.8
|
M
| |
|
|
Market cap: |
$2.75
|
B
| |
|
|
Net cash:
|
$351
|
M
| |
$7.68
|
per share
|
EV:
|
$2.39
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Research and development | 104.4 | 75.9 | 48.8 | 20.2 | 9.3 |
General and administrative | 30.0 | 17.3 | 11.3 | 6.5 | 1.7 |
EBIT | -134.4 | -93.2 | -60.0 | -26.7 | -11.0 |
Pre-tax income | -128.8 | -92.5 | -59.7 | -26.5 | -10.8 |
Income taxes | 0.0 | -2.2 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 2.4% | 0.0% | 0.0% | 0.0% |
Net income | -128.8 | -90.2 | -59.7 | -26.5 | -10.8 |
|
Diluted EPS | ($3.40) | ($3.40) | ($5.59) | ($23.03) | ($21.56) |
Shares outstanding (diluted) | 37.8 | 26.6 | 10.7 | 1.1 | 0.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|